Patents by Inventor Alexander Welle

Alexander Welle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11642052
    Abstract: A method of monitoring a subject for the risk of Acute Mountain Sickness (AMS) includes obtaining real-time pulse arterial oxygen saturation (SpO2) measurements from the subject. The SpO2 measurements are transformed into a novel metric known as Accumulated Hypoxic Debt (AHD). The AHD metric is used as the independent variable in a longitudinal generalized linear mixed model to calculate the probability D that the subject is at risk of AMS. Based on the probability D, appropriate courses of action may be communicated to the subject via the output device of a wearable or portable monitor.
    Type: Grant
    Filed: December 8, 2018
    Date of Patent: May 9, 2023
    Inventors: Beth Beidleman, Mark Buller, Alexander Welles
  • Publication number: 20200146602
    Abstract: A method of monitoring a subject for the risk of Acute Mountain Sickness (AMS) includes obtaining real-time pulse arterial oxygen saturation (SpO2) measurements from the subject. The SpO2 measurements are transformed into a novel metric known as Accumulated Hypoxic Debt (AHD). The AHD metric is used as the independent variable in a longitudinal generalized linear mixed model to calculate the probability D that the subject is at risk of AMS. Based on the probability D, appropriate courses of action may be communicated to the subject via the output device of a wearable or portable monitor.
    Type: Application
    Filed: December 8, 2018
    Publication date: May 14, 2020
    Applicant: THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY
    Inventors: Beth Beidleman, Mark Buller, Alexander Welles
  • Publication number: 20020054851
    Abstract: The invention concerns a radio-labeled antithrombogenic polymer and its use as part of therapeutic means to prevent excessive cell proliferation or scarring, and means which comprise the radiolabeled antithrombogenic polymer, such as emplastrum or artificial implants with a biocompatible coating.
    Type: Application
    Filed: March 30, 2000
    Publication date: May 9, 2002
    Inventors: Michael Grunze, Alexander Welle
  • Patent number: 6022722
    Abstract: The invention relates to a method for the renaturation of denatured proteins in which they are treated with a renaturant which has on vicinal carbon atoms a hydroxyl group and at least one fluorine atom.
    Type: Grant
    Filed: June 1, 1998
    Date of Patent: February 8, 2000
    Assignee: Huels Aktiengesellschaft
    Inventors: Frauke Lohr, Andreas Pawlik, Hubert Motschmann, Martina Bree, Euridice Vieira, Alexander Welle